BROOKS AUTOMATION, INC. (NASDAQ:BRKS) Files An 8-K Entry into a Material Definitive Agreement
Item 1.01.Entry into a Material Definitive Agreement.
On February 15, 2019, Brooks Automation, Inc. (the “Company”), and its subsidiaries, BioStorage Technologies, Inc., Genewiz, Inc. and Genewiz, LLC, entered into that certain Amendment No. 2 (the “Amendment”) to that certain Credit Agreement, dated as of October 4, 2017 (as amended, the “Credit Agreement”), among the Company, the several lenders party thereto from time to time (the “Lenders”), and Morgan Stanley Senior Funding, Inc., as administrative agent for the Lenders, in connection with the loan syndication of the previously announced $350,000,000 incremental term loan obtained by the Company under the Credit Agreement on November 15, 2018.
Under the Amendment, on and after February 15, 2019, the Applicable Margin (as defined in the Credit Agreement) relating to the interest rate applicable to any 2018 Incremental Term B Loan under the Credit Agreement constituting a Eurodollar Loan under the Credit Agreement was changed to 3.00% per annum, and the Applicable Margin relating to the interest rate applicable to any 2018 Incremental Term B Loan under the Credit Agreement constituting an ABR Loan under the Credit Agreement was changed to 2.00% per annum.
The foregoing description of the Amendment does not purport to be complete and is subject to, and qualified in its entirety by reference to, the full terms and conditions of the Amendment, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.All capitalized terms not defined herein shall have the meanings given to such terms in the Amendment or in the Credit Agreement, as applicable.
Item 2.03.Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The information set forth under Item 1.01 is hereby incorporated by reference into this Item 2.03 as if fully set forth herein.
Item 9.01.Financial Statements and Exhibits.
(d) Exhibits
The following exhibit is filed herewith:
|
0 |
|
|
EXHIBIT NUMBER |
DESCRIPTION |
|
10.1 |
Amendment No. 2, dated as of February 15, 2019, to that certain Credit Agreement, dated as of October 4, 2017, among Brooks Automation, Inc., the several lenders party thereto from time to time and Morgan Stanley Senior Funding, Inc., as administrative agent for the Lenders. |
BROOKS AUTOMATION INC Exhibit
EX-10.1 2 brks-20190222ex101ac867c.htm EX-10.1 brks_20190222_Ex10_1 Exhibit 10.1 AMENDMENT NO. 2 AMENDMENT NO. 2,…
To view the full exhibit click here
About BROOKS AUTOMATION, INC. (NASDAQ:BRKS)
Brooks Automation, Inc. is a provider of automation and cryogenic solutions for various applications and markets. The Company operates through two segments: Brooks Semiconductor Solutions Group and Brooks Life Science Systems. The Brooks Semiconductor Solutions Group segment offers critical automated transport, vacuum and contamination controls solutions and services. Its product offerings include robots and integrated automation systems for handling of substrates. It is also a provider of cryogenic components to create vacuum and thermal stability within critical operating environments in the manufacturing process. It also offers equipment for automated contamination control, conditioning and metrology solutions for wafer and reticle carriers. The Brooks Life Science Systems segment offers sample life cycle management solutions that provide life science and bioscience customers with a range of sample management solutions for scientific research and support drug development.
